ESTRADERM TTS 50 Microgram/day Transdermal Patch Ireland - English - HPRA (Health Products Regulatory Authority)

estraderm tts 50 microgram/day transdermal patch

novartis pharmaceuticals uk ltd - estradiol hemihydrate - transdermal patch - 50 microgram/day

ESTRADERM MX 25 25 mcg/24 hr Singapore - English - HSA (Health Sciences Authority)

estraderm mx 25 25 mcg/24 hr

novartis (singapore) pte ltd - estradiol - patch - 0.75 mg/patch

ESTRADERM MX 50 50 mcg/24 hr Singapore - English - HSA (Health Sciences Authority)

estraderm mx 50 50 mcg/24 hr

novartis (singapore) pte ltd - estradiol - patch - 1.5 mg/patch

Calciup D3 Forte 1000mg/880 IU Chewable Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

calciup d3 forte 1000mg/880 iu chewable tablets

rowex ltd - calcium carbonate; cholecalciferol concentrate (powder form) - chewable tablet - 1000mg/880 international unit(s) - calcium, combinations with vitamin d and/or other drugs

XOFIGO Israel - English - Ministry of Health

xofigo

bayer israel ltd - radium-223 dichloride - solution for injection - radium-223 dichloride 1100 kbq/ml at reference date - radium (223 ra) dichloride - xofigo monotherapy or in combination with luteinising hormone releasing hormone (lhrh) analogue is indicated for the treatment of adult patients with metastatic castration-resistant prostate cancer (mcrpc), symptomatic bone metastases and no known visceral metastases, in progression after at least two prior lines of systemic therapy for advanced pc (other than lhrh analogues), or ineligible for any available systemic mcrpc treatment.

XOFIGO Israel - English - Ministry of Health

xofigo

bayer israel ltd - radium-223 dichloride - solution for injection - radium-223 dichloride 1100 kbq/ml at reference date - radium (223 ra) dichloride - xofigo monotherapy or in combination with luteinising hormone releasing hormone (lhrh) analogue is indicated for the treatment of adult patients with metastatic castration-resistant prostate cancer (mcrpc), symptomatic bone metastases and no known visceral metastases, in progression after at least two prior lines of systemic therapy for advanced pc (other than lhrh analogues), or ineligible for any available systemic mcrpc treatment.

ESTRADERM MX Ireland - English - HPRA (Health Products Regulatory Authority)

estraderm mx

novartis pharmaceuticals uk ltd - estradiol - transdermal patch

ESTRADERM MX Ireland - English - HPRA (Health Products Regulatory Authority)

estraderm mx

novartis pharmaceuticals uk ltd - estradiol - transdermal patch

ESTRADERM MX Ireland - English - HPRA (Health Products Regulatory Authority)

estraderm mx

novartis pharmaceuticals uk ltd - estradiol - transdermal patch

ESTRADERM TTS Ireland - English - HPRA (Health Products Regulatory Authority)

estraderm tts

pco manufacturing - transdermal patch - 25 microgram/day